Taysha Gene Therapies, Inc.
Ticker: 1806310
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 | Q2 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 1.99-13.5% | 2.30+28.5% | 1.79+0.0% | 1.79+61.3% | 1.11-67.4% | 3.41-28.2% | 4.75+97.9% | 2.40 |
| Total Income | 1.99-13.5% | 2.30+28.5% | 1.79+0.0% | 1.79+61.3% | 1.11-67.4% | 3.41-28.2% | 4.75+97.9% | 2.40 |
| EXPENSES | ||||||||
| Expenditure | 28.74+21.2% | 23.72-14.3% | 27.69+0.0% | 27.69+23.6% | 22.41-19.2% | 27.74+32.1% | 21.00-18.5% | 25.78 |
| Tax | — | 0.00 | — | — | — | 0.00 | — | — |
| PROFIT | ||||||||
| Net Profit | -26.88-24.8% | -21.53+15.6% | -25.52+0.0% | -25.52-21.9% | -20.93+13.0% | -24.06+79.5% | -117.09-376.0% | -24.60 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.09-12.5% | -0.08+20.0% | -0.10+0.0% | -0.10-11.1% | -0.09+10.0% | -0.10+89.2% | -0.93-144.7% | -0.38 |
Corporate Events
Board MeetingTSHA
20261Jun
Board Meeting
2026 annual meeting of stockholders to vote on the election …
SEC Filing ↗